Biotechnology RETA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Reata Pharmaceuticals, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm November 2, 2020
Biotechnology Arena Pharmaceuticals to Release Third Quarter 2020 Financial Results and Provide Corporate Update on November 9 November 2, 2020
Biotechnology ChemoCentryx to Hold Third Quarter 2020 Financial Results Conference Call on Monday, November 9, 2020 November 2, 2020
Biotechnology Allakos Announces Presentation from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2020 Annual Scientific Meeting November 2, 2020
Biotechnology Bio-Techne To Present At The 29th Annual Credit Suisse Virtual Healthcare Conference November 2, 2020
Biotechnology Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2020 Financial Results November 2, 2020
Biotechnology Amicus Therapeutics to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference November 2, 2020
Biotechnology Rosen, A Top Ranked Law Firm, Reminds Reata Pharmaceuticals, Inc. Investors of Important December 14 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – RETA October 31, 2020
Search
Biotechnology
